These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 5087047)

  • 21. Intra-platelet platelet factor 4 (IP.PF4) and the heparin-mobilisable pool of PF4 in health and atherosclerosis.
    O'Brien JR; Etherington MD; Pashley M
    Thromb Haemost; 1984 Jul; 51(3):354-7. PubMed ID: 6495255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Studies on plasma hypercoagulability. 1. Heparin resistance in various diseases and its relation to coagulation factors, anticoagulant therapy, platelet and heparin co-factor].
    Satake K
    Naika Hokan; 1969 Apr; 16(4):127-38. PubMed ID: 5816626
    [No Abstract]   [Full Text] [Related]  

  • 23. Platelet factor 4 efficiently reverses heparin anticoagulation in the rat without adverse effects of heparin-protamine complexes.
    Cook JJ; Niewiarowski S; Yan Z; Schaffer L; Lu W; Stewart GJ; Mosser DM; Myers JA; Maione TE
    Circulation; 1992 Mar; 85(3):1102-9. PubMed ID: 1537108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of platelet factor 4(DF 4) in hemostasis].
    Kubisz P; Caen J; Pinkhas J
    Cas Lek Cesk; 1971 Apr; 110(14):319-21. PubMed ID: 5552679
    [No Abstract]   [Full Text] [Related]  

  • 25. Influence of platelet factor 4 on the neutralization of heparin by protamine.
    Shanberge JN; Quattrociocchi-Longe TM
    Ann N Y Acad Sci; 1989; 556():354-65. PubMed ID: 2735664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antiheparin and heparin activity of blood in various stages of pregnancy].
    Kreminskaia IaM
    Pediatr Akus Ginekol; 1970; 4():33-5. PubMed ID: 5504823
    [No Abstract]   [Full Text] [Related]  

  • 27. Plasma heparin neutralizing activity. Its use in the evaluation of thrombocytopenia and thrombocytosis.
    Dana B; Carvalho AC; Ellman L
    Am J Clin Pathol; 1976 Jun; 65(6):964-9. PubMed ID: 945687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet factor four and protamine sulfate neutralization of heparin fractionated according to anionic charge density.
    Poon MC; Hurst RE; Rives MS
    Thromb Haemost; 1982 Apr; 47(2):162-5. PubMed ID: 7101237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet factor 3 in membranes and granules of human platelets.
    Farská I; Pudlák P; Posedĕlová H
    Acta Univ Carol Med Monogr; 1972; 53():141-6. PubMed ID: 4670726
    [No Abstract]   [Full Text] [Related]  

  • 30. Some properties of human epidermal growth factor (hEGF)-like immunoreactive material originating from platelets during blood coagulation.
    Kurobe M; Tokida N; Furukawa S; Hayashi K
    Biochem Int; 1986 Nov; 13(5):729-33. PubMed ID: 3545207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Demonstration of endogenous heparin in rat blood.
    Horner AA
    FEBS Lett; 1974 Sep; 46(1):166-70. PubMed ID: 4422583
    [No Abstract]   [Full Text] [Related]  

  • 32. Isolation and characterization of two new Lys49 PLA2s with heparin neutralizing properties from Bothrops moojeni snake venom.
    Perchuc AM; Menin L; Favreau P; Bühler B; Bulet P; Schöni R; Wilmer M; Ernst B; Stöcklin R
    Toxicon; 2010 Jun; 55(6):1080-92. PubMed ID: 20036682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Mechanism of heparin inactivation by thromboplastin (factor III)].
    Byshevskiĭ ASh; Mikhaleva IV; Galenko OV; Tersenov OA
    Ukr Biokhim Zh (1978); 1987; 59(4):3-8. PubMed ID: 3629728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation of a surface glycoprotein of human platelets.
    Lombart C; Okumura T; Jamieson GA
    FEBS Lett; 1974 Apr; 41(1):30-4. PubMed ID: 4136842
    [No Abstract]   [Full Text] [Related]  

  • 35. The isolation and characterisation of a platelet-specific beta-globulin (beta-thromboglobulin) and the detection of antiurokinase and antiplasmin released from thrombin-aggregated washed human platelets.
    Moore S; Pepper DS; Cash JD
    Biochim Biophys Acta; 1975 Feb; 379(2):360-9. PubMed ID: 47244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Complex compounds of heparin with blood proteins and their natural inhibitors in splenectomy in animals].
    Liapina LA; Kondashevskaia MV; Azieva LD; Soboleva GI
    Patol Fiziol Eksp Ter; 1990; (4):20-2. PubMed ID: 2080078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protease-induced immunoregulatory activity of platelet factor 4.
    Katz IR; Thorbecke GJ; Bell MK; Yin JZ; Clarke D; Zucker MB
    Proc Natl Acad Sci U S A; 1986 May; 83(10):3491-5. PubMed ID: 3517862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma antiheparin activity, soluble fibrin monomer complexes and fibrinolysis in plasma of patients after surgery.
    Farbiszewski R; Lipiński B; Lebenstein W
    Thromb Diath Haemorrh; 1969 Nov; 22(2):408-10. PubMed ID: 5380960
    [No Abstract]   [Full Text] [Related]  

  • 39. Plasma heparin neutralizing activity in coronary artery disease.
    Dana B; Ellman L; Carvalho A; Daggett WM; Hutter AM
    Am J Cardiol; 1976 Jul; 38(1):9-11. PubMed ID: 937205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Letter: Heparin thrombin clotting-time and platelet factor 4.
    O'Brien JR; Etherington M; Jamieson S; Lawford P
    Lancet; 1974 Sep; 2(7881):656-7. PubMed ID: 4137779
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.